-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NBKeqQtn8OnfsIMDWXu7sBQLj80MymVXbWXIV3ZdxtNN88wCg7Y9k3uGUCo4+1IV HVghLZ+dLI2+uMoRM9C3HA== 0000912057-01-510419.txt : 20010426 0000912057-01-510419.hdr.sgml : 20010426 ACCESSION NUMBER: 0000912057-01-510419 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRIANGLE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001022622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 561930728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: SEC FILE NUMBER: 333-39118 FILM NUMBER: 1610676 BUSINESS ADDRESS: STREET 1: 4 UNIVERSITY PLACE STREET 2: 4611 UNIVERSITY DRIVE CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 9194935980 MAIL ADDRESS: STREET 1: 4 UNIVERSITY PLACE STREET 2: 4611 UNIVERSITY DRIVE CITY: DURHAM STATE: NC ZIP: 27707 POS AM 1 a2046693zposam.txt POS AM AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 25, 2001 REGISTRATION NO. 333-39118 - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRIANGLE PHARMACEUTICALS, INC. (Exact name of Registrant as Specified in Its Charter) DELAWARE 56-1930728 (State or Other Jurisdiction (I.R.S. Employer of Incorporation or Organization) Identification No.) 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM, NORTH CAROLINA 27707 (919) 493-5980 (Address, Including Zip Code and Telephone, Including Area Code, of Registrant's Principal Executive Offices) DAVID W. BARRY, M.D. CHAIRMAN AND CHIEF EXECUTIVE OFFICER TRIANGLE PHARMACEUTICALS, INC. 4 UNIVERSITY PLACE, 4611 UNIVERSITY DRIVE DURHAM, NORTH CAROLINA 27707, (919) 493-5980 (Name, Address, Including Zip Code and Telephone Number, Including Area Code, of Agent for Service) Copies To: RACHEL MANDELL, ESQ. TRIANGLE PHARMACEUTICALS, INC. 4 UNIVERSITY PLACE, 4611 UNIVERSITY DRIVE DURHAM, NORTH CAROLINA 27707, (919) 493-5980 - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- DEREGISTRATION OF SHARES Triangle Pharmaceuticals is filing this post effective amendment to deregister, as of the date hereof, 304,373 shares of Triangle Pharmaceuticals' common stock remaining unsold at the conclusion of the offering described in the registration statement on Form S-3 (Reg. No. 333-39118). The shares were being offered by selling stockholders of Triangle Pharmaceuticals. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Durham, State of North Carolina, on April 25, 2001. TRIANGLE PHARMACEUTICALS, INC. By: /s/ David W. Barry -------------------------------- David W. Barry CHAIRMAN AND CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
SIGNATURE TITLE - --------------------------------- -------------------------- Chairman of the Board and /s/ David W. Barry Chief Executive Officer - ---------------------------------- (Principal Executive Officer) April 25, 2001 David W. Barry /s/ Chris A. Rallis Director, President and Chief Operating - ----------------------------------- Officer April 25, 2001 Chris A. Rallis Executive Vice President and Chief /s/ Robert F. Amundsen, Jr. Financial Officer - ----------------------------------- (Principal Financial April 25, 2001 Robert F. Amundsen, Jr. and Accounting Officer) * - ----------------------------------- Director April 25, 2001 Anthony B. Evnin * - ----------------------------------- Director April 25, 2001 Standish M. Fleming * - ------------------------------------ Director April 25, 2001 Dennis B. Gillings * - ------------------------------------ Director April 25, 2001 Arthur J. Higgins * - ------------------------------------ Director April 25, 2001 Henry G. Grabowski * - ------------------------------------ Director April 25, 2001 George McFadden *By: /s/ David W. Barry - ------------------------------------- David W. Barry ATTORNEY-IN-FACT
-----END PRIVACY-ENHANCED MESSAGE-----